Please login to the form below

Not currently logged in
Email:
Password:

The Prostate Project kicks of 2016 OctoBeardFest campaign

Aims to raise awareness and funds for prostate cancer research
OctoBeardFest Michael Buerk

The Prostate Project has once again launched its successful OctoBeardFest campaign with the support of long-serving patron the broadcaster Michael Buerk.

Established in 2013, OctoBeardFest calls on men to let their beards grow for the month of October, foregoing the razor to raise money for the Guildford, UK-based prostate charity.

Over £200,000 has been raised so far and is being used to fund a world-class research team at the University of Surrey, led by Professor Hardev Pandha.

Currently, the university researchers are running a 500-man clinical trial of the breakthrough EN2 urine test for prostate cancer, as well as research to help determine how aggressive the cancer is through the development of a blood test.

The team hopes that this research, funded by the Prostate Project's campaign, will lead to tailored diagnostics and medicines that will see advanced prostate cancer patients benefit from a new generation of hormone-targeting drugs.

Last year's OctoBeardFest funded exosome research - tiny particles extracted from the blood that hold vital information on why some patients respond better than others to certain drugs.

A new study collecting exosome samples from men on enzalutamide - the first of the new hormone-targeting drugs - is underway, with results expected by early 2017.

Article by
Rebecca Clifford

23rd September 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics